← Leaderboards
Bin Wang
University Of Pittsburgh At Pittsburgh
$5,294,391
Attributed
$5,294,391
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2013–24$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,294,391 · 6
By mechanism
R01$4,459,519 · 3
R03$462,500 · 2
R21$372,372 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- William Richard Stauffer$17,614,873
- Oliver Schlueter$2,133,471
- Elizabeth Stahl$197,605
- Jeffrey L. Brodsky$8,704,529
- Andrew F. Stewart$27,613,128
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsSignal TransductionParathyroid Hormone ReceptorSignal PathwayResponseMediatingIn VivoCyclic AmpDesignBaseReceptorPreventBone ResorptionGtp-Binding Protein Alpha Subunits, GsPth GeneOsteogenesisOsteoblastsAnabolic AgentsBoneReceptor SignalingOsteoporosisCellsOsteoclastsBeta Catenin
Grant awards (21)
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide$332,904
R01 · FY2024 · AR · contact PI
Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone$320,046
R01 · FY2024 · AG · contact PI
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide$343,200
R01 · FY2023 · AR · contact PI
Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone$320,046
R01 · FY2023 · AG · contact PI
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide$339,768
R01 · FY2022 · AR · contact PI
Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone$320,046
R01 · FY2022 · AG · contact PI
Novel Molecular and Cellular Mechanisms for Osteoanabolic Action of Parathyroid Hormone$380,579
R01 · FY2021 · DK · contact PI
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide$332,904
R01 · FY2021 · AR · contact PI
Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone$324,169
R01 · FY2021 · AG · contact PI
Biasing OGR1 signaling to optimizing PTH therapeutic effect$166,452
R21 · FY2021 · AR · contact PI
Novel Molecular and Cellular Mechanisms for Osteoanabolic Action of Parathyroid Hormone$385,630
R01 · FY2020 · DK · contact PI
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide$343,200
R01 · FY2020 · AR · contact PI
Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone$327,027
R01 · FY2020 · AG · contact PI
Biasing OGR1 signaling to optimizing PTH therapeutic effect$205,920
R21 · FY2020 · AR · contact PI
Novel Molecular and Cellular Mechanisms for Osteoanabolic Action of Parathyroid Hormone$390,000
R01 · FY2019 · DK · contact PI
Novel Mechanism of PTH Effects on Bone Metabolism$77,500
R03 · FY2015 · AR · contact PI
Novel Regulation of PTH Receptor Functions in Bone$77,500
R03 · FY2015 · AR · contact PI
Novel Regulation of PTH Receptor Functions in Bone$77,500
R03 · FY2014 · AR · contact PI
Novel Mechanism of PTH Effects on Bone Metabolism$77,500
R03 · FY2014 · AR · contact PI
Novel Mechanism of PTH Effects on Bone Metabolism$76,250
R03 · FY2013 · AR · contact PI
Novel Regulation of PTH Receptor Functions in Bone$76,250
R03 · FY2013 · AR · contact PI